[Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
10 patients with septicaemia caused by enterobacteriaceae were successfully treated with cefotaxime. 9 patients had previously received unsuccessful antimicrobial therapy. The pathogen was resistant in vitro to other antibiotics. Cefotaxime was administered alone or in combination with an aminoglycoside. No severe side-effects were noted.
D000328:Adult; D000368:Aged; D002439:Cefotaxime; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy*
D002511:Cephalosporins; D002439:Cefotaxime
Place du céfotaxime dans le traitement des septicémies à entérobactéries. 10 observations.